Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2000
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067734A2 Use of phthalazine derivatives
11/16/2000WO2000067700A2 Recombinant vaccine against botulinum neurotoxin
11/16/2000WO2000067698A2 Method for controlling the fidelity and execution of reverse transcriptase by incorporating and polymerising nucleotide analogues acceptable as substrates without blocking its elongation
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000067575A1 0623hk
11/16/2000WO2000048996A3 β-ALANINE DERIVATIVES
11/16/2000WO2000047223A3 Viral vaccine
11/16/2000WO2000044406A3 Dna vaccines against hantavirus infections
11/16/2000WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000042168A3 Bifidobacterium in the treatment of inflammatory disease
11/16/2000WO2000040242A3 Preparation of a composition against hepatitis b-, hi-, paramyxo- and orthomyxoviruses
11/16/2000WO2000039287A3 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof
11/16/2000WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000030653A3 Use of phosphonoformic acid derivatives for treating infections
11/16/2000WO2000026224A3 Novel macrolide antibiotics
11/16/2000WO2000025721A3 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation
11/16/2000WO2000024907A3 Library of novel "unnatural" natural products
11/16/2000WO2000020556A3 Zinc finger-reactive antimicrobial compounds
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000018365A3 Fast dissolving orally consumable films
11/16/2000WO2000015634A3 Hiv protease inhibitors
11/16/2000WO2000007631A9 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
11/16/2000DE19922407A1 Preparing medicament for treating viral infections, liver diseases or cancer, comprising recombinant parapoxvirus targeted towards specific organs, cells or tissues
11/16/2000DE19921567A1 Verwendung von Phthalazine-Derivaten Use of derivatives phthalazines
11/16/2000DE19920247A1 Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung Medicaments with an amount of compounds having a nitrogen-oxygen heterocycle as active ingredient and their use
11/16/2000DE19919149A1 Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Of interferon alpha-2 derived peptide homodimers and peptide heterodimers
11/16/2000CA2388092A1 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373672A1 Method for controlling the fidelity and execution of reverse transcriptase by incorporating and polymerising nucleotide analogues acceptable as substrates without blocking its elongation
11/16/2000CA2373447A1 Permeabilizing biofilms
11/16/2000CA2373182A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000CA2373079A1 Substituted benzolactam compounds
11/16/2000CA2373073A1 Cyclic compounds and uses thereof
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2372961A1 Halo- or hydroxy-substituted nocathiacin antibiotics
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372791A1 Thiazepine and oxazepine inhibitors of hiv-1 integrase
11/16/2000CA2372782A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
11/16/2000CA2372704A1 Use of phthalazine derivatives
11/16/2000CA2371902A1 Novel nucleic acids and proteins with interferon-beta activity
11/16/2000CA2371279A1 Recombinant vaccine against botulinum neurotoxin
11/16/2000CA2369323A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000CA2368831A1 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/15/2000EP1052254A1 Nitrogenous heterocyclic derivatives and medicine thereof
11/15/2000EP1052250A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/15/2000EP1051978A1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same
11/15/2000EP1051486A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051433A2 Antimicrobial peptides
11/15/2000EP1051428A1 Human cystatin f
11/15/2000EP1051413A1 Quinoline derivatives as antibacterials
11/15/2000EP1051405A2 Novel dihydroxyhexanoic acid derivatives
11/15/2000EP1051395A1 Hydroxamic and carboxylic acid derivatives
11/15/2000EP1051195A1 Identification of agents that protect against inflammatory injury to neurons
11/15/2000EP1051193A1 Anhydrous topical skin preparations
11/15/2000EP1051190A1 Vaccine compositions for mucosal administration comprising chitosan
11/15/2000EP1051180A1 Phospholipids having antimicrobial activity with or without the presence of antimicrobials
11/15/2000EP1051175A1 Use of bicozamycin for the manufacture of a medicament for treating infections with enterohemorrhagic e. coli
11/15/2000EP1051169A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
11/15/2000EP1051156A2 Pharmaceutical compositions
11/15/2000EP0650371B1 Covalent polar lipid-peptide conjugates for biological targeting
11/15/2000CN1273588A Amino acid sequences for therapeutical and prophylacticapplications to disedses due to i (clostridium difficile) toxinc
11/15/2000CN1273587A Process for preparation of 3-cephem compounds
11/15/2000CN1273111A Ointment for treating skin tinea
11/15/2000CN1273110A Chinese medicine for curing viral myocarditis
11/15/2000CN1273100A Anticancer detoxicating pill and its preparing process
11/15/2000CN1273092A Water-soluble powdered quinolone medicines
11/15/2000CN1058496C Process for isolating or purifying cefonicid and process for preparing salts thereof
11/15/2000CN1058405C Chinese medical for treating foot and mouth disease
11/15/2000CN1058392C Disinfecting anti-inflammatory pill and preparing method
11/14/2000US6147199 Viricides
11/14/2000US6147197 6-O-substituted erythromycin ketolides having antibacterial activity
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147117 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/14/2000US6147116 Polyaromatic antiviral compositions
11/14/2000US6147097 Imidazole derivatives as anti-HIV agents
11/14/2000US6147095 Administering combination of tipranavir and ritonavir for treatment of hiv
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147077 2R,4S-hydroxyitraconazole isomers
11/14/2000US6147061 Antiarthritic agents; anticancer agents; oral diseases
11/14/2000US6147057 Immunogenic composition
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146902 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
11/14/2000US6146868 Nucleotide and amino acid sequence of enzyme which deacetylates component of fungal capsule; fungicides for treatment of cryptococcosis
11/14/2000US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase
11/14/2000US6146846 Primosome protein a of streptococcus pneumoniae
11/14/2000US6146837 Detecting fc gamma receptor (cd64) in a biological sample by conacting sample with cyanin compound, cy5; illuminating the sample with light of an appropriate excitation wavelength; and detecting fluorescence
11/14/2000US6146829 Gapped 2' modified oligonucleotides
11/14/2000US6146643 A hepatitis a virus having a genome consisting of a human attenuated hepatitis a virus sequence wherein the 5' noncoding region has been replaced by the 5' noncoding region of simian hepatitis a virus agm-27
11/14/2000US6146642 Recombinant new castle disease virus RNA expression systems and vaccines
11/14/2000US6146641 Avian leukosis virus subgroup J envelope gene product for diagnosis and immunogenic composition
11/14/2000US6146635 System for the expression of heterologous antigens as fusion proteins
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146629 Hybridoma cell line producing human monoclonal antibodies capable of binding to the hepatitis b virus surface antigen
11/14/2000US6146622 Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
1 ... 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 ... 1798